SCHEMBL7801329

SCHEMBL7801329

CCc1cc(OC)c(C(=O)O)cc1C(=O)N(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
HSD17B10 Q99714 2/20 0.41
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
MAPK1 P28482 1/20 0.40
PDE5A O76074 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18309197 0.87 KDM4E (0.53) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL3969837 0.84 KDM4E (0.40) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL3969835 0.79 PDE3B (0.38) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL13469242 0.78 LCK (0.58) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL8902437 0.76 KDM4E (0.53) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL8189899 0.76 KDM4E (0.49) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL15462887 0.76 KDM4E (0.49) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL12444067 0.75 ALDH1A1 (0.64) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL13469246 0.73 MAPT (0.49) KDM4EALDH1A1HPGDLCKFYN
Hydrochloric Acid SCHEMBL28599506 0.73 ALDH1A1 (0.62) KDM4EALDH1A1HPGDLCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2001-09-27 US disclosed
EP-1025087-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-08-09 EP disclosed
WO-1999021836-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A KDM4E 910/4885ALDH1A1 494/4885HPGD 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.